Literature DB >> 28821597

A randomised controlled trial assessing the efficacy of an electronic discharge communication tool for preventing death or hospital readmission.

Maria J Santana1, Jayna Holroyd-Leduc1,2, Danielle A Southern1, Ward W Flemons2, Maeve O'Beirne3, Michael D Hill1,2,4, Alan J Forster5, Deborah E White6, William A Ghali7.   

Abstract

OBJECTIVE: To assess the efficacy of an electronic discharge communication tool (e-DCT) for preventing death or hospital readmission, as well as reducing patient-reported adverse events after hospital discharge. The e-DCT assessed has already been shown to yield high-quality discharge summaries with high levels of patient and physician satisfaction.
METHODS: This two-arm randomised controlled trial was conducted in a Canadian tertiary care centre's internal medicine medical teaching units. Out of the 1953 patients approached and screened for inclusion, 1399 were randomised and available for data linkage for determination of the primary outcome. Participants were randomly assigned to e-DCT versus usual care (traditional discharge communication generated by dictation). The primary outcome was a composite of death or readmission within 90 days. The secondary outcome included any patient-reported adverse events within 30 days of discharge.
RESULTS: Among 1399 randomised participants, 230 of 701 participants (32.8%) in the e-DCT group experienced the primary composite outcome of death or readmission within 90 days vs 205 of 698 participants (29.4%) in the usual care group (p=0.166). The incidence at 30 days of patient-reported adverse outcomes (35% for e-DCT vs 34% for usual care) and adverse events (2.1% for e-DCT vs 1.8% for usual care) also did not differ significantly between groups.
CONCLUSIONS: The e-DCT tested did not reduce the composite endpoint of death or readmission at 90 days, nor the incidence of patient-reported adverse events at 30 days. This neutral finding for hard clinical endpoints needs to be considered in the context of high patient and physician satisfaction, and high quality of discharge summaries. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Mesh:

Year:  2017        PMID: 28821597     DOI: 10.1136/bmjqs-2017-006635

Source DB:  PubMed          Journal:  BMJ Qual Saf        ISSN: 2044-5415            Impact factor:   7.035


  6 in total

1.  Effect of health information technology (HIT)-based discharge transition interventions on patient readmissions and emergency room visits: a systematic review.

Authors:  Joanna Abraham; Alicia Meng; Sanjna Tripathy; Spyros Kitsiou; Thomas Kannampallil
Journal:  J Am Med Inform Assoc       Date:  2022-03-15       Impact factor: 4.497

Review 2.  Recommendations for the Design and Delivery of Transitions-Focused Digital Health Interventions: Rapid Review.

Authors:  Hardeep Singh; Terence Tang; Carolyn Steele Gray; Kristina Kokorelias; Rachel Thombs; Donna Plett; Matthew Heffernan; Carlotta M Jarach; Alana Armas; Susan Law; Heather V Cunningham; Jason Xin Nie; Moriah E Ellen; Kednapa Thavorn; Michelle LA Nelson
Journal:  JMIR Aging       Date:  2022-05-19

Review 3.  Impact of electronic health records on predefined safety outcomes in patients admitted to hospital: a scoping review.

Authors:  Christian Peter Subbe; Genevieve Tellier; Paul Barach
Journal:  BMJ Open       Date:  2021-01-13       Impact factor: 2.692

4.  Improving continuity of care of patients with respiratory disease at hospital discharge.

Authors:  Jack Dummer; Tim Stokes
Journal:  Breathe (Sheff)       Date:  2020-09

5.  Improving patient understanding on discharge from the short stay unit: an integrated human factors and quality improvement approach.

Authors:  Jenna Lauren Elizabeth Cook; Evie Fioratou; Peter Davey; Lynn Urquhart
Journal:  BMJ Open Qual       Date:  2022-08

6.  Prospective economic evaluation of an electronic discharge communication tool: analysis of a randomised controlled trial.

Authors:  Laura K Sevick; Maria-Jose Santana; William A Ghali; Fiona Clement
Journal:  BMJ Open       Date:  2017-12-14       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.